Phase II Trial of IL-12 Plasmid Transfection and PD-1 Blockade in Immunologically Quiescent Melanoma

Algazi, A. P., Twitty, C. G., Tsai, K. K., Le, M., Pierce, R., Browning, E., Hermiz, R., Canton, D. A., Bannavong, D., Oglesby, A., Francisco, M., Fong, L., Pittet, M. J., Arlauckas, S. P., Garris, C., Levine, L. P., Bifulco, C., Ballesteros-Merino, C., Bhatia, S., Gargosky, S., Andtbacka, R. H., Fox, B. A., Rosenblum, M. D. and Daud, A. I.  Phase II Trial of IL-12 Plasmid Transfection and PD-1 Blockade in Immunologically Quiescent Melanoma.  Clinical Cancer Research.  2020; 26(12), 2827-2837.  doi: 10.1158/1078-0432.ccr-19-2217

Privacy Preference Center

Necessary

Advertising

Analytics

Other